Price T Rowe Associates Inc Zomedica Corp. Transaction History

Price T Rowe Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.12 - $0.19 $33,132 - $52,459	276,100 Added 41.07%	948,300 $139,000
Q4 2023 Feb 14, 2024	BUY	$0.15 - $0.22 $28,020 - $41,096	186,800 Added 38.48%	672,200 $135,000
Q3 2023 Nov 14, 2023	BUY	$0.16 - $0.23 $24,544 - $35,282	153,400 Added 46.2%	485,400 $82,000
Q4 2022 Feb 14, 2023	BUY	$0.16 - $0.25 $23,040 - $36,000	144,000 Added 76.6%	332,000 $54,000
Q1 2022 May 16, 2022	BUY	$0.28 - $0.4 $20,132 - $28,760	71,900 Added 61.93%	188,000 $63,000
Q4 2021 Feb 14, 2022	SELL	$0.31 - $0.58 $121,024 - $226,431	-390,400 Reduced 77.08%	116,100 $36,000
Q3 2021 Nov 15, 2021	SELL	$0.46 - $0.81 $58,006 - $102,141	-126,100 Reduced 19.93%	506,500 $265,000
Q2 2021 Aug 16, 2021	BUY	$0.72 - $1.46 $176,256 - $357,408	244,800 Added 63.13%	632,600 $527,000
Q1 2021 May 17, 2021	BUY	$0.35 - $2.7 $135,730 - $1.05 Million	387,800 New	387,800 $613,000

80.9M

Ticker ZOM
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 979,950,016
Market Cap $127M
Description
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.